InsidersTradesSigma
Discover the full insider trade history of Ascelia Pharma AB, a publicly traded company based in Finland. Shares are quoted on FI FI, under the oversight of FIN-FSA. Operating in the Healthcare sector, Ascelia Pharma AB has logged 1 public disclosures. Market capitalisation: €393.3m. The latest transaction was reported on 23 September 2025 — Purchase. Among the most active insiders: Peter Benson. The full history is accessible without an account.
FY ended December 2025 · cache
0 of 0 declarations